Skip to main content

Echo evaluation of Heart Failure, LVAD and Transplanted Heart - ASE Echocardiography Lectures

 

Complete Lecture on Echocardiographic evaluation of Heart Failure, LVAD and Transplanted Heart by Karima Addetia, M.D. FACC, FASE. - ASE Echocardiography board review lecture. 

 

Lecture Highlights: 00:00 Intro to assessment of LVAD on Echocardiography 00:11 Why Offer an LVAD? 00:50 LVADs: Clinical Indications 01:38 LVAD Circuit 02:06 HeartMate II and HVAD (HeartWare) 02:57 Pre LVAD placement and Post LVAD Placement 03:24 LVAD Hemodynamics 05:01 Clinical Indications of Echocardiography in LVAD 05:30 ECHO in the LVAD Patinet 05:35 LVAD Parameters 05:49 LVAD Evaluation on Echo 06:18 LVAD Surveillance on Echo 08:11 InterVentricular Septum and Left Ventricular Size 08:18 Position of InterVentricular Septum 10:53 Thrombosis in LVAD 12:52 Aortic Valve Opening in LVAD 13:22 M Mode Echo AV Opening in LVAD 14:36 Aortic Insufficiency in LVAD 16:37 Inflow Cannula 20:30 Outflow cannula 23:00 Troubleshooting of LVAD - Case 1 26:05 LVAD Speed Optimization 26:46 The RAMP Study 29:35 Optimization of LV Unloading 30:52 Optimization of Aortic Valve Opening 31:54 Optimization of Mitral Regurgitation 32:17 Example of RAMP Study 35:30 LVAD Malfunction Case 37:41 Echocardiography Post Heart Transplantation 40:39 Bi-Atrial vs Bi-CAVAL Heart Transplant on Echo 41:02 Transthoracic Echo in Heart Transplant Patients 43:30 Increased Wall Thickness in Heart Transplant Recipients 44:49 Right ventricle assessment following Heart Transplant 46:17 Right ventricle Parameters 47:14 Diastolic Dysfunction in Transplanted Heart 50:28 Heart Transplant Rejection 50:54 Acute Rejection (ACR) 51:33 Post Endomyocardial Biopsy 53:56 Chronic Rejection (CAV) 55:01 Detecting Rejection of Heart Transplant on Echo 56:32 Deformation Analysis 57:49 Stress Echo for Detection of Rejection 58:32 Post Heart Transplant Complications 59:15 Summary After attending this lecture you will be able to answer the following questions: What is the importance of Echocardiography in the assessment of LVAD? What is LVAD? What is Left Ventricular assisst device for Heart? How to assess function of LVAD on Echocardiogrpahy? What are the clinical indications of LVAD? What are the parameters to assess LVAD on Echo? What is RAMP Study? Troubleshooting of LVAD with case examples How to optimize LVAD Settings? What is Inflow and outflow cannula of LVAD? How to optimize LVAD speed? Hemodynamics of LVAD on Echocardiography How to assess tranplanted Heart on Echocardiography? How to detect acute rejection of Heart Transplant on Echocardiography? How to detect Chronic rejection of Heart Transplant on Echocardiography? #echocardiography #HeartTransplant #LVAD #Transplant #troubleshooting #device #cardiology #Echo #ASE #boardreview #heartfailure #transplant

Labels:

Comments

Post a Comment

Drop your thoughts here, we would love to hear from you

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...
1 comment
Latest Posts »

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...
Post a Comment
Latest Posts »

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.
1 comment
Latest Posts »